LITS
Lite Strategy, Inc.
There isn't enough reported data to score LITS yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
LITS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| Unavailable | |
| Strong |
LITS's balance sheet is currently strong, and its profitability is stable, but its revenue is weak. There isn't enough data to rate its cash flow.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
LITS PE Valuation
LITS has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
LITS Forward outlook
There aren't enough analyst estimates for LITS to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
LITS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.46 | -$0.15 |
| Q2 2026 | -$2.06 | +$0.33 |
| Q1 2026 | -$2.00 | +$2.75 |
| Q4 2025 | -$1.73 | +$4.00 |
| Q3 2025 | -$1.31 | +$5.68 |
| Q2 2025 | -$2.39 | -190% |
| Q1 2025 | -$4.75 | -226% |
| Q4 2024 | -$5.73 | -303% |
LITS is still losing money, but far less than before: $1.46 per share over the past year, against $14.80 at its worst in early 2021.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over LITS on earnings quality, reporting a profit while its opponent remains loss making.
LITS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2023 | $65.3M | +648% |
| Q2 2023 | $1.5M | -87% |
| Q1 2023 | $5.9M | -39% |
| Q4 2022 | $32.7M | +177% |
| Q3 2022 | $8.7M | +13% |
| Q2 2022 | $11.4M | -41% |
| Q1 2022 | $9.7M | +301% |
| Q4 2021 | $11.8M | +29% |
LITS's revenue has slid since its 2023 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2023 | 85% | +293 points |
| Q2 2023 | -760% | -619 points |
| Q1 2023 | -278% | -56 points |
| Q4 2022 | 27% | +176 points |
| Q3 2022 | -209% | +51 points |
| Q2 2022 | -142% | -124 points |
| Q1 2022 | -222% | +691 points |
| Q4 2021 | -149% | +61 points |
LITS's operating margin was 85% last quarter, up 293 points from the same quarter a year ago, near the top of its range since 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
LITS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.2M | +$2.3M |
| Q2 2026 | -$1.2M | +$1.3M |
| Q1 2026 | -$1.5M | +$1.7M |
| Q3 2025 | -$4.5M | +$6.9M |
| Q2 2025 | -$2.5M | +$15.5M |
| Q1 2025 | -$3.3M | -$339K |
| Q3 2024 | -$11.5M | +$7M |
| Q2 2024 | -$18M | -$6.7M |
LITS has burned cash in almost every quarter: −$7M over the past year, against −$22M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over LITS on cash generation, producing positive trailing cash flow while its opponent burns cash.
LITS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4% | -1.4M shares |
| 1 year | +13% | +3.7M shares |
| 3 years | +398% | +26.5M shares |
| 5 years | +483% | +27.5M shares |
| Available history | +744% | +29.3M shares |
LITS has 33M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4M |
| Q2 2026 | $2.9M |
| Q1 2026 | $1.8M |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over LITS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
LITS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | -0.1x | Net Cash |
| Q4 2023 | -0.3x | Net Cash |
| Q3 2023 | -0.1x | Net Cash |
LITS has more cash than debt.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
LITS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 24.0 | Neutral |
LITS's weekly RSI is 40 (neutral) and its Stochastic is 24 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
LITS PE vs Healthcare Sector
| Metric | LITS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
LITS has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
LITS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.18 | 23% below |
| 20 week MA | $1.07 | 15% below |
| 50 week MA | $1.14 | 20% below |
| 100 week MA | $1.98 | 54% below |
| 200 week MA | $3.41 | 73% below |
LITS is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over LITS on trend strength, trading above more of its moving averages.
LITS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.4 | $58.0 | +34% |
| 2021 | $58.0 | $51.4 | -11% |
| 2022 | $51.4 | $5.00 | -90% |
| 2023 | $5.00 | $5.80 | +16% |
| 2024 | $5.80 | $2.44 | -58% |
| 2025 | $2.44 | $1.35 | -45% |
| 2026 YTD | $1.35 | $0.91 | -33% |
LITS has finished lower in four of the last six years. It's down 33% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over LITS on returns for 2026, with the stronger performance.